Cargando…

Recommendations for the Definition of Clinical Responder in Insulin Preservation Studies

Clinical responder studies should contribute to the translation of effective treatments and interventions to the clinic. Since ultimately this translation will involve regulatory approval, we recommend that clinical trials prespecify a responder definition that can be assessed against the requiremen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beam, Craig A., Gitelman, Stephen E., Palmer, Jerry P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141373/ https://www.ncbi.nlm.nih.gov/pubmed/24722251 http://dx.doi.org/10.2337/db14-0095

Ejemplares similares

Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes
por: Haller, Michael J., et al.
Publicado: (2016)

Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study
por: Mamza, J, et al.
Publicado: (2014)

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
por: Sosenko, Jay M., et al.
Publicado: (2020)

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin
por: Holden, Sarah E, et al.
Publicado: (2011)

Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance
por: Ho, David, et al.
Publicado: (2015)

Anti-Insulin Receptor Antibodies Improve Hyperglycemia in a Mouse Model of Human Insulin Receptoropathy
por: Brierley, Gemma V., et al.
Publicado: (2020)

Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo
por: Konstantopoulos, Nicky, et al.
Publicado: (2012)

Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
por: Sarruf, David A., et al.
Publicado: (2010)

Identification of a Small Molecular Insulin Receptor Agonist With Potent Antidiabetes Activity
por: Qiang, Guifen, et al.
Publicado: (2014)

Effect of Rosiglitazone on Bone Quality in a Rat Model of Insulin Resistance and Osteoporosis
por: Sardone, Laura D., et al.
Publicado: (2011)

Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog
por: Edgerton, Dale S., et al.
Publicado: (2014)

Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice
por: Tan, Carina P., et al.
Publicado: (2008)

In Vivo Pancreatic β-Cell–Specific Expression of Antiaging Gene Klotho: A Novel Approach for Preserving β-Cells in Type 2 Diabetes
por: Lin, Yi, et al.
Publicado: (2015)

A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control
por: Bhaskar, Vinay, et al.
Publicado: (2012)

Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes
por: Duan, Franklin F., et al.
Publicado: (2015)

Proinsulin-Transferrin Fusion Protein as a Novel Long-Acting Insulin Analog for the Inhibition of Hepatic Glucose Production
por: Wang, Yan, et al.
Publicado: (2014)

Pck1 Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in db/db Mice
por: Gómez-Valadés, Alicia G., et al.
Publicado: (2008)

Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes
por: Spectre, Galia, et al.
Publicado: (2012)

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers
por: Christensen, Alexander S., et al.
Publicado: (2020)

Insulin Reduces Cerebral Ischemia/Reperfusion Injury in the Hippocampus of Diabetic Rats: A Role for Glycogen Synthase Kinase-3β
por: Collino, Massimo, et al.
Publicado: (2009)

Phenotypic Type 2 Diabetes in Obese Youth: Insulin Sensitivity and Secretion in Islet Cell Antibody–Negative Versus –Positive Patients
por: Tfayli, Hala, et al.
Publicado: (2009)

Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study
por: O Riordan, David, et al.
Publicado: (2018)

Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes
por: Chow, Elaine, et al.
Publicado: (2023)

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
por: Xu, Jing, et al.
Publicado: (2009)

Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity
por: Si, Yiling, et al.
Publicado: (2012)

Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes
por: Serrano-Marco, Lucía, et al.
Publicado: (2011)

Statin use and clinical outcomes in older men: a prospective population-based study
por: Gnjidic, Danijela, et al.
Publicado: (2013)

Severity of coeliac disease and clinical management study when using a non-metabolised medication: a phase I pharmacokinetic study
por: Chretien, Marc L, et al.
Publicado: (2023)

Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
por: Nyman, Sofi Sennefelt, et al.
Publicado: (2022)

Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981–2014: a retrospective observational study
por: Ward, Derek J, et al.
Publicado: (2015)

Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study
por: Chretien, Marc L, et al.
Publicado: (2020)

Fall incidents in nursing home residents: development of a predictive clinical rule (FINDER)
por: Milosevic, Vanja, et al.
Publicado: (2021)

Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre- and post-clinical pharmacists' interventional study
por: Khalili, Hossein, et al.
Publicado: (2012)

Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia
por: Sendekie, Ashenafi Kibret, et al.
Publicado: (2023)

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD
por: Davis, Alan K, et al.
Publicado: (2023)

Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial
por: Nyang'wa, Bern-Thomas, et al.
Publicado: (2021)

Development in the number of clinical trial applications in Western Europe from 2007 to 2015: retrospective study of data from national competent authorities
por: Dombernowsky, Tilde, et al.
Publicado: (2017)

Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy
por: Trotta, Francesco, et al.
Publicado: (2017)

Prevalence, clinical relevance and predictive factors of medication discrepancies revealed by medication reconciliation at hospital admission: prospective study in a Swiss internal medicine ward
por: Giannini, Olivier, et al.
Publicado: (2019)

Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study
por: Moore, Thomas J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_32kr82mjk45g0ci0lhijjcsogi